SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-025869
Filing Date
2022-02-02
Accepted
2022-02-02 17:02:58
Documents
12
Period of Report
2022-01-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d274026d8k.htm   iXBRL 8-K 44894
  Complete submission text file 0001193125-22-025869.txt   168948

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA crtx-20220128.xsd EX-101.SCH 2862
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE crtx-20220128_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crtx-20220128_pre.xml EX-101.PRE 10816
6 EXTRACTED XBRL INSTANCE DOCUMENT d274026d8k_htm.xml XML 3231
Mailing Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 415-910-5717
Cortexyme, Inc. (Filer) CIK: 0001662774 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38890 | Film No.: 22584549
SIC: 2836 Biological Products, (No Diagnostic Substances)